速騰聚創(02498.HK)授出總計880萬份購股權
格隆匯6月4日丨速騰聚創(02498.HK)公告,於2025年6月4日,公司根據首次公開發售後股份激勵計劃向45名承授人(均爲集團員工)授出總計880萬份購股權,可於行使購股權時以行使價每股股份33.52港元認購一股股份。
首次公開發售後股份激勵計劃爲公司提供靈活性,可通過購股權、受限制股份或受限制股份單位向合資格參與者授出激勵。公司相信,本次向作爲集團員工的承授人授予首次公開發售後股份激勵計劃項下的購股權可以使這些員工與股東的個人利益保持一致、激勵員工的卓越業績、爲集團的持續經營及發展吸引及留住人才,從而進一步促進集團的成功與發展、提升公司價值,以及爲股東帶來回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.